LT2016044A - Topinė kompozicija su aktyviaisiais junginiais iš c. sativa ir c. officinalis skirta odos pažeidimų mažinimui - Google Patents

Topinė kompozicija su aktyviaisiais junginiais iš c. sativa ir c. officinalis skirta odos pažeidimų mažinimui

Info

Publication number
LT2016044A
LT2016044A LT2016044A LT2016044A LT2016044A LT 2016044 A LT2016044 A LT 2016044A LT 2016044 A LT2016044 A LT 2016044A LT 2016044 A LT2016044 A LT 2016044A LT 2016044 A LT2016044 A LT 2016044A
Authority
LT
Lithuania
Prior art keywords
topical composition
reduction
officinalis
skin lesions
emollient
Prior art date
Application number
LT2016044A
Other languages
English (en)
Other versions
LT6485B (lt
Inventor
Juozas Šiurkus
Rimantas PEČIŪRA
Original Assignee
UAB "SatiMed"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UAB "SatiMed" filed Critical UAB "SatiMed"
Priority to LT2016044A priority Critical patent/LT6485B/lt
Priority to PCT/IB2017/051911 priority patent/WO2017175126A1/en
Priority to EP17721853.4A priority patent/EP3439678A1/en
Priority to US16/091,049 priority patent/US11364273B2/en
Publication of LT2016044A publication Critical patent/LT2016044A/lt
Publication of LT6485B publication Critical patent/LT6485B/lt
Priority to US17/826,188 priority patent/US11813301B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/678—Tocopherol, i.e. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Šis išradimas pateikia topinę kompoziciją, apimančią esminių sinergetiškai veikiančių fito-aktyvių medžiagų derinį, kuriame yra nepsichotropiniai fitokanabinoidai iš Cannabis sativa augalo: kanabidiolis (CBC), kanabidiolinė rūgštis (CBDA), kanabivarinas (CBV) kanabigerolis (CBG) kartu su medetkų žiedų (Calendula officinalis) ekstraktu ir bazine kompozicija, užtikrinančia priešuždegimines, antioksidacines, minkštinamąsias ir baktericidines komponentų funkcijas. Ši topinė kompozicija yra minkštiklis, skirtas sumažinti odos sutrikimams, kuriuos sukelia atopinis dermatitas, dilgėlinė, radioterapija ir UV pažaidos bei aknė. Be to, topinė kompozicija gali sumažinti riebalų išsiskyrimą, palengvinti giluminį odos drėkinimą, sumažinti poras ir pasižymi raminančiu poveikiu.@@@@18
LT2016044A 2016-04-04 2016-04-04 Topinė kompozicija su aktyviaisiais junginiais iš c. sativa ir c. officinalis skirta odos pažeidimų mažinimui LT6485B (lt)

Priority Applications (5)

Application Number Priority Date Filing Date Title
LT2016044A LT6485B (lt) 2016-04-04 2016-04-04 Topinė kompozicija su aktyviaisiais junginiais iš c. sativa ir c. officinalis skirta odos pažeidimų mažinimui
PCT/IB2017/051911 WO2017175126A1 (en) 2016-04-04 2017-04-04 The topical composition with active compounds from cannabis sativa and calendula officinalis for reduction of skin lesions
EP17721853.4A EP3439678A1 (en) 2016-04-04 2017-04-04 The topical composition with active compounds from cannabis sativa and calendula officinalis for reduction of skin lesions
US16/091,049 US11364273B2 (en) 2016-04-04 2017-04-04 Topical composition with active compounds from Cannabis sativa and Calendula officinalis for reduction of skin lesions
US17/826,188 US11813301B2 (en) 2016-04-04 2022-05-27 Topical composition with active compounds from Cannabis sativa and Calendula officinalis for reduction of skin lesions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LT2016044A LT6485B (lt) 2016-04-04 2016-04-04 Topinė kompozicija su aktyviaisiais junginiais iš c. sativa ir c. officinalis skirta odos pažeidimų mažinimui

Publications (2)

Publication Number Publication Date
LT2016044A true LT2016044A (lt) 2017-10-25
LT6485B LT6485B (lt) 2018-01-10

Family

ID=58671739

Family Applications (1)

Application Number Title Priority Date Filing Date
LT2016044A LT6485B (lt) 2016-04-04 2016-04-04 Topinė kompozicija su aktyviaisiais junginiais iš c. sativa ir c. officinalis skirta odos pažeidimų mažinimui

Country Status (4)

Country Link
US (2) US11364273B2 (lt)
EP (1) EP3439678A1 (lt)
LT (1) LT6485B (lt)
WO (1) WO2017175126A1 (lt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3103178A1 (en) 2017-06-27 2019-01-03 Enviro BioMedical Laboratories Inc. Blended cannabis compounds and methods of making the same
RU2675254C1 (ru) * 2017-11-20 2018-12-18 Наталья Бегиевна Мигачева Способ профилактики атопического дерматита у детей раннего возраста
CN107837218A (zh) * 2017-11-20 2018-03-27 广东博然堂生物科技有限公司 一种护肤品及其制备方法
WO2019186544A1 (en) * 2018-03-26 2019-10-03 Raphael Luxenbourg Topical cannabidiol compositions and methods for protecting the skin from ultra-violet radiation
ES2966110T3 (es) 2018-04-04 2024-04-18 Vinsan Therapeutics Inc Formulaciones e instilados de cannabinoides tópicos, kits y métodos para tratar heridas tegumentarias y usos de los mismos
CN108283704A (zh) * 2018-04-26 2018-07-17 马玉玲 一种治疗痤疮的外用药
IT201800020590A1 (it) 2018-12-20 2020-06-20 Arterra Bioscience S P A Uso cosmetico, farmaceutico e nutraceutico di un estratto derivato da colture cellulari di Cannabis sativa
WO2020178385A1 (en) * 2019-03-06 2020-09-10 Isdin, S.A. Use of caprylic and capric triglycerides for the treatment of a disease or condition mediated by filaggrin or collagen deficiency
CN113766841A (zh) * 2019-04-30 2021-12-07 格林威草本产品有限责任公司 大麻素组合物和用法
CN110269839A (zh) * 2019-06-15 2019-09-24 云南飞久逍科技有限公司 一种大麻二酚cbd及其纳米乳在荨麻疹或/和鼻炎制剂中的应用
CA3149121A1 (en) 2019-07-29 2021-02-04 Echo Pharmaceuticals B.V. Treatment of inflammatory skin conditions
CA3149120A1 (en) 2019-07-29 2021-02-04 Echo Pharmaceuticals B.V. Treatment of sebaceous gland disorders
CA3057647A1 (en) * 2019-10-03 2021-04-03 Vinsan Therapeutics Inc. Topical formulations and instillates, kits, and methods for treating integumentary wounds, and uses thereof
EP4017471A1 (en) * 2019-10-07 2022-06-29 Colgate-Palmolive Company Personal care compositions and methods
CA3158384A1 (en) * 2019-11-20 2021-05-27 Canole Llc Combination cannabinoid-phenylethanoid formulation for treatment of inflammation and methods related thereto
AU2020407254B2 (en) * 2019-12-16 2023-12-07 Colgate-Palmolive Company Personal care compositions and methods for the same
WO2022016160A1 (en) * 2020-07-17 2022-01-20 India Globalization Capital, Inc. Cannabidiol (cbd) based composition and method for treating pain
AU2021327215A1 (en) * 2020-08-18 2023-05-04 Gbs Global Biopharma, Inc. Cannabinoid-containing complex mixtures for the treatment of cytokine release syndrome while preserving key anti-viral immune reactions
WO2022098366A1 (en) * 2020-11-09 2022-05-12 Redwood Ip Holding, Llc Skincare compositions for preventing transepidermal water loss
CN112315863B (zh) * 2020-11-10 2021-12-03 山东百奥生物医药有限公司 一种舒缓光电术中疼痛热感的组合物及制备方法和应用
CN112472644A (zh) * 2020-12-16 2021-03-12 魏华 一种丝瓜提取物护手霜及其制备方法
KR102558352B1 (ko) * 2023-01-13 2023-07-24 주식회사 코스모바이오 대마 추출물을 유효성분으로 포함하는 피부 개선용 화장료 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6949582B1 (en) 1999-05-27 2005-09-27 Wallace Walter H Method of relieving analgesia and reducing inflamation using a cannabinoid delivery topical liniment
DE102007046086A1 (de) 2007-09-26 2009-04-09 Heinz Prof. Dr. Letzel Pflanzenextrakt aus THC-armen Cannabis zur Behandlung von Erkrankungen
PL2444081T3 (pl) 2010-10-19 2015-09-30 Parenteral A S Kompozycja do leczenia chorób zapalnych, zawierająca kwas bosweliowy i kannabidiol
GB201019297D0 (en) 2010-11-15 2010-12-29 Pitt Elaine Improved compositions
US20120264818A1 (en) 2011-04-15 2012-10-18 Jon Newland Topical Compositions with Cannabis Extracts
US8642645B2 (en) * 2011-05-20 2014-02-04 Brooks Kelly Research, LLC. Pharmaceutical composition comprising Cannabinoids

Also Published As

Publication number Publication date
LT6485B (lt) 2018-01-10
WO2017175126A1 (en) 2017-10-12
US20190111093A1 (en) 2019-04-18
US11364273B2 (en) 2022-06-21
US20220296664A1 (en) 2022-09-22
US11813301B2 (en) 2023-11-14
EP3439678A1 (en) 2019-02-13

Similar Documents

Publication Publication Date Title
LT2016044A (lt) Topinė kompozicija su aktyviaisiais junginiais iš c. sativa ir c. officinalis skirta odos pažeidimų mažinimui
Baswan et al. Therapeutic potential of cannabidiol (CBD) for skin health and disorders
Baumann Less‐known botanical cosmeceuticals
WO2012135337A3 (en) Topical skin care formulations comprising plant extracts
de Souza et al. Photochemoprotective effect of a fraction of a partially purified extract of Byrsonima crassifolia leaves against UVB-induced oxidative stress in fibroblasts and hairless mice
US11446232B2 (en) Natural skin penetrating moisturizer formulations
PH12017500706A1 (en) Composition containing extract or fraction of genus justicia plant
EA201401031A1 (ru) Полутвёрдая композиция для местного применения, которая содержит пирфенидон и модифицированный диаллилдисульфид оксид (m-ddo) для удаления или предупреждения угрей
US20150086522A1 (en) Formulation containing herb infused aloe
MX2012013642A (es) Composiciones farmaceuticas topicas que comprenden furoato de mometasona.
WO2014041542A3 (en) Topical compositions for the treatment of acne
AR109277A1 (es) Composición y método para el tratamiento de las afecciones de la piel
WO2011085013A3 (en) Vitamin c composition for use in the prevention and treatment of stretch marks, radiation dermatitis, and other skin conditions and methods of using the same
TR201903470T4 (tr) Kişisel hijyen için formülasyon.
AR084197A1 (es) Composicion para uso topico para el tratamiento de trastornos de la piel
Ha et al. Antioxidant and antibacterial activities of Glycyrrhiza uralensis Fisher (Jecheon, Korea) extracts obtained by various extract conditions
CN102188355A (zh) 一种保湿止痒润肤乳液
AR085655A1 (es) Extracto de cinnamomum burmanii, proceso de extraccion y su uso como regulador por disminucion de la bomba de protones, inhibidor enzimatico, y mucoprotector
AR102008A1 (es) Ingrediente farmacéutico activo (ifa) oleoso para el tratamiento de afecciones de la piel, composiciones que lo comprenden y su uso para prepararlas
Turegano et al. Cosmeceuticals for acne and rosacea
WO2012048446A8 (zh) 锁阳化学成分作为植物雌激素的新用途
Cho et al. Antioxidative activity and protein expression effects of the extracts from Cinnamomum camphora on the hair-growth relevant factors
CN104971010A (zh) 一种温和型除皱面膜
Zohreh et al. Medicinal herbs effective on the skin
Sajeeda et al. Naringenin, a flavanone constituent from Sea buckthorn pulp extract, prevents ultraviolet (UV)-B radiation-induced skin damage via alleviation of impaired mitochondrial dynamics mediated inflammation in human dermal fibroblasts and Balb/c mice models

Legal Events

Date Code Title Description
BB1A Patent application published

Effective date: 20171025

FG9A Patent granted

Effective date: 20180110